Targeted therapy – News, Research and Analysis – The Conversation

Pancreatic cancer has been notoriously difficult to target and treat. wildpixel/iStock via Getty Images Plus

August 26, 2026

FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival

Christopher Lieu, University of Colorado Anschutz

Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these tumors so deadly.

Pancreatic cancer has been notoriously difficult to treat. Steve Gschmeissner/Science Photo Library via Getty Images

June 2, 2026

Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease

Christopher Lieu, University of Colorado Anschutz

Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target the mechanism that makes these tumors so deadly.

Lung cancer is the No. 1 cause of cancer-related deaths worldwide. vladwel/iStock via Getty Images Plus

October 25, 2021

A new way to organize cancer mutations could lead to better treatment matches for patients

Jacqulyne Robichaux, The University of Texas MD Anderson Cancer Center

Every cancer is different. Grouping cancer mutations by their structure and function could help make treatments more personalized.

Articles on Targeted therapy

Displaying all articles

FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival

Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease

A new way to organize cancer mutations could lead to better treatment matches for patients

Top contributors

Articles on Targeted therapy

Displaying all articles

Related Topics

Top contributors

Links